More on SPRC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (7/24/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SciSparc (NQ:SPRC)
Delayed: 5.08 +0.13 (2.63%)
Prev. Close $4.95  
Open$5.27 
52 Wk High$ 
52 Wk Low$ 
Day High$5.27 
Day Low$5.00 
P/E N/A  
EPS$ 
Volume11,580 

Friends, Peers and Foes (?): CMND, NITO, NTLX, CWY0 80W (more...)

Sep 2, 2026 08:17 AM SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
Aug 31, 2026 04:03 PM SciSparc autism trial enrolls 26 of 60 planned children for SCI-210
Aug 31, 2026 04:03 PM SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
Aug 26, 2026 04:01 PM Form 6-K SciSparc Ltd. For: Aug 26
Aug 26, 2026 08:32 AM SciSparc adds Technion AI professor to advisory board
Aug 26, 2026 08:32 AM SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
Aug 24, 2026 09:22 AM Form 6-K SciSparc Ltd. For: Aug 24
Aug 24, 2026 08:51 AM SciSparc unit files U.S. patent for MDMA-PEA combination for PTSD
Aug 24, 2026 08:51 AM SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Aug 19, 2026 04:04 PM SciSparc (SPRC) files for 2.6M share offering by selling stockolders
View All Articles

Entities mentioned with SPRC

View All Entities